Peter Lio

Search results

• Biorasi Featured in AOBiome B244 Clinical Study Report in The Lancet’s eClinicalMedicine

  Peter Lio

  16/05/23

  82 items of Media coverage

  Press/Media

• FDA: Roflumilast Foam NDA Accepted for Seborrheic Dermatitis

  Peter Lio

  19/04/23

  1 item of Media coverage

  Press/Media

• April 18th 2023

  Peter Lio

  18/04/23

  1 item of Media coverage

  Press/Media

• An Overview of Atopic Dermatitis (AD)

  Peter Lio

  14/04/23

  2 items of Media coverage

  Press/Media

• FDA Accepts Roflumilast Foam NDA for the Treatment of Seborrheic Dermatitis

  Peter Lio

  1/04/23

  1 item of Media coverage

  Press/Media

• FDA: Roflumilast Foam NDA Accepted for Seborrheic Dermatitis

  Peter Lio

  1/04/23

  1 item of Media coverage

  Press/Media

• Molluscum Contagiosum Update: Two New Treatments Come Down the Pike

  Peter Lio

  21/03/23

  1 item of Media coverage

  Press/Media

• Top news of February: COVID-19 vaccines, ocular surface disease, FDA approvals, more

  Peter Lio

  3/03/23

  1 item of Media coverage

  Press/Media

• Speaker: Diet not likely cause of atopic dermatitis

  Peter Lio

  16/02/23

  1 item of Media coverage

  Press/Media

• New Atopic Dermatitis Study Findings Have Been Published by a Researcher at Northwestern University Feinberg School of Medicine (326 Dupilumab: a comparison of infection rates across atopic dermatitis trials in adults, adolescents, children and ...)

  Peter Lio

  13/02/23

  1 item of Media coverage

  Press/Media

• Experts React to Approval of Pfizer’s CIBINQO for Teens with Refractory AD

  Emma Guttman & Peter Lio

  12/02/23

  1 item of Media coverage

  Press/Media

• Game On: Top Derm Video Game Boosts Clinical Decision Making Among Seasoned Doctors

  Peter Lio

  31/01/23

  1 item of Media coverage

  Press/Media

• CDC Report: Seven Percent of Adults and 11 Percent of Kids Had Eczema in 2021

  Peter Lio

  30/01/23

  1 item of Media coverage

  Press/Media

• About 1 in 3 American Adults Has an Allergy

  Peter Lio

  26/01/23 → 27/01/23

  111 items of Media coverage

  Press/Media

• About 1 in 3 American Adults Has an Allergy.

  Peter Lio

  26/01/23

  1 item of Media coverage

  Press/Media

• Eczema: Experimental drug shows promise in treating atopic dermatitis

  Peter Lio

  19/01/23 → 24/01/23

  2 items of Media coverage

  Press/Media

• Exploring the link between IBD and psoriasis

  Peter Lio

  17/01/23

  1 item of Media coverage

  Press/Media

• Oh, What a Year!

  Peter Lio

  22/12/22

  1 item of Media coverage

  Press/Media

• Recent Findings from Northwestern University Feinberg School of Medicine Highlight Research in Atopic Dermatitis [Evaluating the predictive utility of patient-oriented scoring of atopic dermatitis (PO-SCORAD) versus Patient-Oriented Eczema ...]

  Peter Lio

  21/12/22

  1 item of Media coverage

  Press/Media

• The Climb Up: Psoriasis Care Reaches New Heights in 2022

  Mark Lebwohl & Peter Lio

  14/12/22

  2 items of Media coverage

  Press/Media

• Positive New Results of Tapinarof Cream Study for Pediatric Patients with AD

  Peter Lio

  11/11/22

  1 item of Media coverage

  Press/Media

• ASLAN PHARMACEUTICALS LIMITED: ASLAN Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update

  Peter Lio

  28/10/22

  1 item of Media coverage

  Press/Media

• ASLAN Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update

  Peter Lio

  28/10/22

  54 items of Media coverage

  Press/Media

• ASLAN Pharmaceuticals Reports Third Quarter 2022 Financial Results And Provides Corporate Update

  Peter Lio

  28/10/22

  1 item of Media coverage

  Press/Media

• Abrocitinib demonstrates rapid efficacy in treating atopic dermatitis

  Peter Lio

  28/10/22

  1 item of Media coverage

  Press/Media